Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87,621 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suramin inhibits phenotypic transformation of vascular smooth muscle cells and neointima hyperplasia by suppressing transforming growth factor beta receptor 1 /Smad2/3 pathway activation.
Xu Y, Ge L, Rui Y, Wang Y, Wang Z, Yang J, Shi Y, Dong Z, Zhang Y, Zhang R, Yang T, Lv L, Xiang F, Chen S, Song A, Li T, Liu M, Guo Y. Xu Y, et al. Among authors: chen s. Eur J Pharmacol. 2024 Apr 5;968:176422. doi: 10.1016/j.ejphar.2024.176422. Epub 2024 Feb 15. Eur J Pharmacol. 2024. PMID: 38365108
Calcitonin Inhibits Phenotypic Switching of Aortic Smooth Muscle Cells and Neointimal Hyperplasia through the AMP-Activated Protein Kinase/Mechanistic Target of Rapamycin Pathway.
Liu M, Xiang F, Yang T, Sun Y, Yang J, Wang T, Chen S, Xu Y, Shan G, Shi Y, Dong Z, Guo Y. Liu M, et al. Among authors: chen s. ACS Pharmacol Transl Sci. 2024 Feb 23;7(3):733-742. doi: 10.1021/acsptsci.3c00288. eCollection 2024 Mar 8. ACS Pharmacol Transl Sci. 2024. PMID: 38481691
87,621 results
You have reached the last available page of results. Please see the User Guide for more information.